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The organization of Sproximal c-myb exons in chicken DNA has been established by restriction enzyme mapping and 
nucleotide sequencing. Hybridization studies performed with cDNA probes revealed that yolk sac and thymic c-myb 
RNAs differ in their Stermini. A comparison of the genomic c-myb sequence with that of cDNAs isolated from normal 
thymic and lymphoma avian cells suggests that different promoter regions are used to initiate c-myb transcription in he- 
matopoietic ells of different origins. 
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1. INTRODUCTION 
The avian c-myb proto-oncogene is the cellular 
progenitor of the v-myb oncogene transduced by 
avian myeloblastosis virus and avian erythroblas- 
tosis virus E26. The viral sequences only represent 
a fraction of the cellular gene [1,2] whose precise 
boundaries in the genome have yet to be deter- 
mined. Both chicken c-myb and viral v-myb 
products are nuclear proteins of 75 and 45 kDa, 
respectively [3-51. The c-myb gene appears to have 
been conserved during evolution, as shown by the 
isolation and characterization of homologous 
genes in human, mouse and fruitfly DNA [6-81. 
There is also a growing body of evidence sug- 
gesting that the c-myb product is involved in dif- 
ferentiation and proliferation of hematopoietic 
cells. For example, increased levels of c-myb 
transcripts have been detected following stimula- 
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tion of mature human resting T cells [9- 1 l] and 
transcription of c-myb has been reported primarily 
in immature hematopoietic cells of all lineages 
[ 12,131, at all phases of the cell cycle [ 141. Consis- 
tent with these observations, elevated levels of c- 
myb RNA transcripts were detected in yolk sac 
cells and thymus [12,15] in accordance with the 
chronology of hematopoiesis in yolk sac, thymus, 
bone marrow, and spleen during the embryonic 
and early post-embryonic period in chicken [ 161. 
To date, different c-myb cDNAs have been 
isolated from avian B cell lymphoma [17], avian 
normal thymic cells [15], murine pre-B cell lym- 
phoma [ 181, murine myeloid leukemia [7] and 
human T lymphoma [19]. Interestingly, the pro- 
teins encoded by the lymphoma and myeloid 
leukemia cDNAs are very similar, while they differ 
significantly in their amino terminus from the pro- 
tein encoded by the normal chicken thymic cells 
cDNA (fig. 1). 
As a first step in our study of the factors govern- 
ing the expression of the c-myb proto-oncogene 
during differentiation, we have undertaken a 
characterization of the 5 ‘-proximal c-myb exons 
and corresponding regulatory sequences in chicken 
DNA. 
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YetAla Arg Arg Pro Arg His Ser Ile Tyr Ser Ser Asp . . 
. . . . . . AGC CCC GCC GCC CGC CGC GCCATGGCC CGAAGA CCC CGG CAC AGC ATA TAT AGC AGT GAC . . 
t4stAla Arg Arg Pro Arg His Ser Ile Tyr Ser Ser Asp . . MURINE 
. . . . . . CGGAGC CCG GCC CGC CTC GCC ATGGCC CGG AGA CCC CGA CAC AGC ATC TAC AGT AGC GAT . . (Lymphoma) 
MetAla Arg Arg Pro Arg His Ser Ile Tyr Ser Ser Asp . . MURINE 
. . . . . . GGA GCC CCG GCC CGC CTC GCC ATGGCC CGG AGA CCC CGA CAC AGC ATC TAC AGT AGC GAT ._ (Leukemia) 
'NotAla Arg Arg Pro Arg His Ser Ile Tyr Ser Ser Asp . . AVIAN 
. . . . . . TCC CCCAGC GGC CGC CGGAGG ATGGCC CGG AGA CCC CGG CAC AGC ATA TAC AGC AGC GAT . . (Lymphoma) 
(Lymphoma) 
M&Ala Ser Ile . . . Pro Pro Ala Ala Ala Ala Arg Met Ala Arg Arg Pro Arg His Ser Ile Tyr Ser Ser Asp . . . AVIAN 
ATGGCG TCC ATC . . . CCC CCA GCG GCC GCC GCG AGG ATG GCC CGG AGA CCC CGG CAC AGC ATA TAC AGC AGC GAT . . . (Normal thymus) 
Fig. 1. Structural comparison of the amino-terminal portion of c-myb proteins encoded by tumoral and normal tissues from different 
origins. The putative proteins encoded by the RNA expressed in lymphoma and leukemia cells of different origins show a very high 
degree of homology. Only their amino termini have been represented, with part of the corresponding leader sequences. The normal 
avian thymic protein would contain 58 additional amino acids. The ATG initiation codon recognized in other proteins encodes an 
internal methionine in thymic c-myb RNA. 
Here, we report the genomic organization and 
sequencing of 5 ’ -proximal c-myb exons in chicken 
DNA with the localisation of the ATG initiation 
codon previously identified in the c-nzyb cDNA 
from avian B cell lymphoma. We also show that 
the thymic c-myb cDNA profoundly diverges in its 
5 ‘-terminus from the c-nzyb mRNA species ex- 
pressed in normal yolk sac hematopoietic ells. 
2. MATERIALS AND METHODS 
2.1. Preparation of poiyadenylated RNA from normal 
hematopoietic chicken cells: agarose gels and transfer to 
nitrocellulose 
Yolk sac cells expressing the c-myb 4.0 kb mRNA species 
were prepared from 13-day-old embryos as described [20]. 
Total and polyadenylated RNAs were prepared according to 
standard methods [21]. RNA species were separated on 1% 
agarose gels containing formaldehyde 1211 and transferred onto 
nitrocellulose for hybridization with specific probes [21]. 
2.2. Labeling of probes and hybridization 
All probes were prepared from cloned fragments. The DNA 
inserts were purified following digestion with appropriate 
restriction endonucleases, electrophoresis in agarose or 
polyacrylamide gels (depending on the size of the fragment o 
be purified) and elution under the conditions in [21]. 
Labeling of DNA longer than 300 bp was performed by nick 
translation in the presence of [a-“P]dCTP. Short DNA 
fragments were labeled with [c~-~*P]~CTP by using the Boeh- 
ringer random priming kit. 
2.3. Cloning of DNA fragments: digestion with restriction 
endonucleases 
Preparation of DNA fragments and selection of recombinant 
clones were performed as in [21]. The recipient vectors were 
pBR322, pUCl8, Ml3 mpl8 and Ml3 mp19. 
Restriction endonucleases were purchased from New England 
Biolabs or Bethesda Research Laboratories and used under the 
conditions recommended by the suppliers. 
2.4. DNA sequencing 
Sequencing was performed by the dideoxy chain-termination 
method of Sanger et al. as described elsewhere [21]. Sequencing 
primers were purchased from New England Biolabs. (cu-“S)- 
labeled dATP (New England Nuclear) and the Klenow fragment 
of E. coli DNA polymerase I (Boehringer or New England 
Biolabs) were used in sequencing reactions. Sequence data 
treatments were performed using the computer facilities at 
CITIZ in Paris on a PDP8 computer, with the help of the 
French Minis&e de la Recherche et de la Technologie (Pro- 
gramme mobilisateur ‘Essor des Biotechnologies’). 
3. RESULTS 
3.1. Organization of the 5 ‘-proximal c-myb exons 
in chicken DNA 
3.1.1. Identification of genomic DNA fragments 
containing c-myb sequences homologous to 
yolk sac RNA 
DNA sequences homologous to the AMV v-myb 
oncogene were previously mapped on the chicken 
genome [1,2,22,23]. Several A recombinant con- 
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taining genomic fragments located upstream and 
downstream of these c-&r sequences were 
characterized [2]. Two of them (h1041, h121) were 
shown to contain the c-myb exon corresponding to 
the 5 ’ -proximal v-myb sequences of AMV [l] in a 
628 bp P&I fragment located at the 3 ’ -end of the 
cellular insert (fig.2). h1041 DNA was digested 
with several restriction endonucleases and a partial 
restriction map was established (fig.2). Five dif- 
ferent fragments generated after a double PstI- 
EcoRI digestion of P542 DNA [2] were subcloned 
in pUC18 (EP180, Pst049, Pst174, Pst063, 
PE080), radiolabeled by nick translation and used 
to probe c-myb RNA species in yolk sac RNA. The 
results obtained (not shown) revealed that in addi- 
tion to those contained in Pst063, the c-myb se- 
quences were contained in Pst174 and Pst049 
DNA. A similar approach performed with P804 
DNA did not permit the detection of any DNA se- 
quences homologous to yolk sac RNA in this 
8.0 kb fragment. 
3.1.2. Sequencing of the 5 ’ -proximal c-myb exons 
The strategy followed for sequencing is depicted 
in fig.2. The identification of the different c-myb 
exons in P542 and P804 DNA could be established 
by comparing our sequence data with the cDNA 
sequences previously published. Three c-myb ex- 
ons were mapped upstream to that located in 
Pst063 (and corresponding to the 5 ‘-end of v-myb 
sequences) (fig.3). 
A 72 bp exon was localized at positions 423-494 
from the 3’-end of the Pst174 clone. Both the 5’- 
and 3 ’ -boundaries of this exon correspond to con- 
sensus splice acceptor and donor sequences 
(AG/GA and CT/GT, respectively). 
Another 118 bp exon, also delineated by consen- 
sus splice acceptor (AGKA) and splice donor 
(AG/GT) sequences, was identified at the 5 ‘-end 
of the DNA fragment contained in clone PstO49 
(see fig.2). The 5 ‘-end of this exon is located 5 bp 
downstream of the 3 ‘-proximal PstI site 
(CTGCAG) of EP180. 
In order to identify the splice donor sequences 
from the exon located upstream in the genomic 
DNA, we took advantage of the fact that a rare 
restriction site (NotI) is located in the 5 ‘-proximal 
portion of c-myb cDNA. Only two Not1 restriction 
sites were mapped at the 3 ‘-end of P804 DNA 
(fig.2), in a 1.0 kb Sac1 fragment and a 0.9 kb 
SacI-EcoRI fragment. In the vicinity of the Not1 
restriction site, the lymphoma cDNA sequence 
is missing a 13 bp stretch of nucleotides 
(CCCCCGTCCTCTT) which is present in both 
thymic cDNA and genomic DNA (fig.4). The ex- 
istence of mismatches between the nucleotide se- 
A1041 
c- - d-h -c1---.-- 0-m -cc -- 
- - -I) - -- 
1Kb 
- 
Fig.2. Derivation of DNA clones and sequence strategy used to map c-myb exons in chicken DNA. The structure of clone A1041 has 
been described [2]. P542 and P804 are subcloned in pBR322 and pUC18, respectively. Only the restriction sites used for subcloning 
and sequencing (arrows) are indicated. E, EcoRI; S, SacI; P, PHI; B, BsmI; N, NotI; Pv, PvuII. 
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quences of lymphoma and thymic cDNAs was 
already stressed by Gerondakis and Bishop [17]. 
Although they might result from different ex- 
perimental procedures used for cDNA cloning and 
nucleotide sequencing, it is also possible that these 
differences are related with the various origins of 
the samples analyzed. 
Sequencing performed in both directions from 
the 3 ‘-proximal Sac1 site allowed us to show that 
in this region, both genomic DNA and thymic 
cDNA are 100% homologous up to a Sac11 restric- 
tion site, where they diverge considerably (fig.4). 
On the other hand, the 5 ‘-proximal sequence of 
lymphoma cDNA and genomic DNA are identical 
upstream to this site. Therefore, the CCTCCC 
might correspond to the 3 ‘-boundary of an intron 
which would not be represented in the thymic 
cDNA, but would be contained in lymphoma 
cDNA. Interestingly, this sequence does not cor- 
respond to a consensus splice acceptor signal. A 
consensus splice donor sequence (AG/GT) is 
located 20 nucleotides downstream of the ATG in- 
itiation codon, as reported for murine c-myb [18]. 
As discussed below, the ATG codon localized in 
the 5 ‘-proximal exon that we have mapped cor- 
responds to the c-myb initiation codon identified 
thus far in mouse and human lymphoma cells and 
to an internal methionine codon in the cDNA 
isolated from normal thymus cell RNA (figs 3,5). 
In order to determine whether the leader and 
5 ’ -coding sequences found specifically in thymic 
cDNA were also contained in P804 DNA, we have 
sequenced several subclones around other restric- 
tion sites represented in the 5 ‘-region of this 
cDNA. Nucleotide sequencing performed in both 
directions from the Sac1 and BsmI sites (fig.2) did 
not allow us to identify any further c-myb se- 
quence in P804 DNA. 
We have obtained preliminary results indicating 
that the DNA sequences homologous to the 
5 ‘-non-coding region contained in thymic cDNA 
are located several kilobases upstream of P804. 
3.2. c-myb mRNAs with different 5 ‘-leader 
sequences are expressed in avian yolk sac and 
thymic hematopoietic ells 
The nucleotide sequence of the avian c-myb 
cDNAs which have been isolated from thymic cells 
and B cell lymphoma cells diverge greatly in their 
5 ‘-end, while c-myb cDNAs isolated from lym- 
phoma cells of different origins show a high degree 
of homology (fig. 1). In order to determine whether 
these differences result from the tumoral origin of 
the cDNA, we screened normal RNA species from 
yolk sac cells for the presence of a leader sequence 
homologous to that found upstream to the ATG 
initiation codon identified in thymic cDNA. For 
this purpose, we isolated the 5 ‘-proximal XhoI- 
NcoI fragment containing leader sequences from 
this cDNA and used it as a probe, after labeling 
with [cuP2P]dCTP. Yolk sac cell RNA elec- 
trophoresed on formaldehyde agarose gel and 
transferred onto nitrocellulose was incubated for 
hybridization with this probe under the conditions 
described in section 2. The internal NcoI fragment 
spanning from positions 1 to 453 in the thymic 
cDNA [15] was used as a positive control. This 
fragment contains a stretch of 66 nucleotides 
homologous to the v-myb sequences which are also 
represented in yolk sac RNA. As shown in fig.4, 
the 4.0 kb c-myb RNA species normally expressed 
in yolk sac cells was detected by the internal NcoI 
Fig.3. Topography of 5’-proximal c-myb exons in chicken DNA. (Top) The organization of the c-myb exons in chicken DNA (B) has 
been drawn from mapping and sequencing performed on the h recombinant clones whose EcoRI (B) restriction maps are shown in 
(A). Open boxes denote c-myb sequences represented in the AMV v-myb oncogene, while filled boxes represent c-myb-specific exons. 
(B) The dashed part of the 5 ‘-proximal c-myb exon designates a non-coding sequence in lymphoma cDNA and a coding sequence in 
thymic cDNA (C). A stretch of 22 nucleotides representing leader sequences in lymphoma cDNA (in front of the dashed exon) is 
probably removed as intron sequences during the maturation of thymic RNA because it is absent in the corresponding cDNA (C). 
The position of three ATG codons is indicated. From 5’ to 3’ they correspond to potential translation initiation sites in thymic, 
lymphoma and yolk sac c-myb mRNAs. As shown in fig.5, the thymic and lymphoma cDNA sequences diverge completely upstream 
to the position marked with an arrow in (C). (Bottom) Nucleotide sequences of c-myb exons. El-E3 represent the 5’-proximal c-myb- 
specific coding sequences found in lymphoma cDNA. E(T) delineates the beginning of additional coding sequences contained in thymic 
cDNA. Homology between c-myb and v-myb sequences starts at E4. Intron boundaries are represented by italics. Putative regulatory 
sequences and translation initiation codons are underlined. 
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E E A 1041 
I I 
Y 
E E EE E Xl2l 
I I 
EE E E E A 322112 
EE E E EE E E E 
I I I 
5’ 3’ 
ymk cDNA 
-E(T) 
. . . . . AACCTGTTTCCTCCTCCTCCTCCCGCGGCTCCTCGGCACTTCGCTGCGCGGCGGCGGAGCGCCTGGGCGCAGCCCGGCAGC 
Sac II 
-El El- 
AGGGCGCGGCGGCGGGCGCGGGCTCCCCCGTCCTCTTCCCCCA CGCGAGG-GCCCGGAGACCCCGGCACAGGT 
AACGGGGC........ ..AATACTAGAACAACAGAATGCAm TCTTGTTGTGCAAGTTTTAAAACTTTTATCTGTGTAACCTTTGTAA 
,E2 
AGATTGTGTGTTTTCTGTGTGCTGTG- GTAGCTCCAGTCCTCACGTTCCGCTCTGTGTCTCGCTGTGTTTCCTG~TATAC 
Pst I 
E2, ,E3 
TAGGGAAAACCAGGTGGACCCGTGAAGAGSTAATTGCCG........ ..AATGATCCAGGATGAGAAACTGAAGAAACTTGTGGAA 
E3, ,E4 
CAGAATGGCACAGAAGACTGGAAAGTCATTGCCAGTTTTCCTTCCTGTAGGTAGAC..........ATTTCATTAGAATCGGACAGA 
TGTTCAGTGCCAG... 
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MC CTG TTT CCT CCT CCT CCT C_~CTCCTCGGCA~TTCGCTOCGCGGCCGCGGAGCGCCTGGGCGCAGCCCGGCAGC 
MC CTG TTT CCT CCT CCT CCT CCCGCGGCTCCTCGGCACTTCGCTGCG-GGCGGCGGAG-G-CTGGGC--AG-CCGGCAGC 
GTG GM ACG GAC GM TGC GM CCC GCGGCT CCT CGGCAC TTC GCT GCGCGGCGGCGGAGC GCC TGGGCGCAGCCC GGCAGC 
Not1 
AGGGCGCGGCGGCGGGCGCGGGCTCCCCCGTCCTCTTCCCCCAGCGGCCGCCGCGAG~CCCGGAGACCCCGGCICIQ 
AGGGCGCGGCGGCGGGCG-GGGCT -------------CCCCCAGCGGCCGCCG-GAG~CCCGGAGACCCCGGCA~G 
AGGGCGCGGCGGCGGGCGCGGGCTCCCCCGTCCTCTTCCCCCAGCGGCCGCCGCGAGG~GCCCGGAGACCCCGGCACAG 
G_TA ACG GGG CGG GGG TTC CGC GCT GTC ACA CGG GG. 
CATATACAGCAGCGATGACGATGAAGAAGAT.. 
CATATACAGCAGCGATGACGATGAAGAAGAT.. 
Fig.4. Comparison of avian cDNAs and genomic 5’-proximal c-my6 sequences. (A) The 5’-proximal sequences of avian lymphoma 
[2] and thymic [3] c-myb cDNAs have been aligned with the c-myb nucleotide sequence that we have established in chicken DNA [l]. 
A perfect matching was obtained between thymic cDNA and genomic sequences downstream of the SucII restriction site. Comparison 
of the three sequences allows us to locate a non-consensus potential splice acceptor sequence (CCTm in addition to the consensus 
splice donor signal (AWGT) located 20 bases downstream of the fiinitiation codon. Sequences homologous to thymic cDNA are 
indicated by boldface letters. Intron sequences are represented by italics. Note the stretch of 13 nucleotides (CCCCCGTCCTCTT) 
present in both thymic cDNA and genomic DNA but absent in the lymphoma cDNA. 
probe, whereas no hybridization occurred with the 
‘leader’ probe (XhoI-NcoI). Three other faint A Thymic cDNA 
bands (3.4, 2.9, 2.5 kb) also detected by the inter- x N N 
nal NcoI probe might correspond to minor c-m@ 
species also expressed in yolk sac cells. These 
results indicate that the sequences located directly 
upstream to the ATG initiation codon in thymic 
cDNA are not expressed in yolk sac cells of 13-day- 
old chicken embryos. 
Fig.5. Hybridization of yolk sac cell RNA with c-myb cDNA 
probes. Total RNA was purified from yolk sac cells of 13-day- 
old chicken embryos under the conditions described in section 
2. Two aliquots (10 ,ug each) of the same RNA preparation were 
run on a 1% formaldehyde agarose gel and blotted onto 
nitrocellulose as in [21]. The thymic c-myb cDNA previously 
cloned in Bluescript vector (Rosson, D., personal 
communication) was digested with XhoI and NcoI restriction 
endonucleases. The (XhoI-NcoI) 110 bp fragment containing 
thymic leader sequences, and the (NcoI-NcoI) 450 bp fragment 
containing the 5’-proximal c-myb coding sequences were 
purified by electrophoresis in polyacrylamide gel, and 
radiolabeled to be used as probes. (A) Derivation of the probes. 
(B) Autoradiography of Northern blots hybridized with the 
leader probe (1) and with the internal NcoI fragment (2). 
B 
1 2 
Kb 
4.4- 
2.1 - 
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4. DISCUSSION 
Several c-myb cDNAs have been isolated and se- 
quenced from different sources [7,15,18,19]. All 
the cDNAs isolated from tumor cells show very 
high homology in their 5 ‘-coding sequences, in- 
dependently of their origin (human, mouse or 
chicken). The isolation of a cDNA corresponding 
to c-myb RNA expressed in normal chicken thymic 
cells [15] has posed several fundamental problems 
regarding the regulation of expression of this 
proto-oncogene. In this cDNA, the ATG triplet, 
identified in all other cDNAs as a potential initia- 
tion codon, encodes for an internal methionine at 
amino acid position 59 from the N-terminus of the 
putative corresponding protein (fig.1). Thus, a 
stretch of 120 nucleotides identified as non-coding 
leader sequences in chicken lymphoma cDNA ap- 
pears to encode 40 amino acids of the thymic c- 
myb protein. Upstream of this position (cor- 
responding to amino acid 20 in thymic cDNA, and 
nucleotide position - 120 in lymphoma cDNA) the 
two sequences diverge completely. 
Aside from possible rearrangements occurring in 
tumor cell DNA, alternative splicing of c-&r 
RNA was proposed to account for these observa- 
tions [17]. In this case, one additional exon (at 
least) would be present at the 5’-end of the c-myb 
locus and transcription would proceed from a pro- 
moter region located further upstream. Our se- 
quencing data allowed us to localize precisely the 
boundaries of the 5’-proximal exon containing the 
ATG initiation codon of lymphoma cDNA, the ad- 
ditional coding sequences represented in thymic 
cDNA and the putative corresponding intron/exon 
junction. The potential splice acceptor signal 
located at this junction does not fall within the 
general consensus whereas a consensus splice 
donor sequence (AGKA) lies 20 nucleotides 
beyond the ATG codon, as reported in the case of 
murine c-myb cDNA [ 181. Several examples of 
non-consensus donor splice signals have been 
reported for c-myb exons [l] and in the case of a 
few other chicken genes [24]. 
A comparison of the genomic nucleotide se- 
quence that we have established with that of 
thymic and lymphoma cDNAs [15,17] revealed 
other interesting features regarding the expression 
of c-myb RNA in avian hematopoietic cells. As 
shown in fig.4 we have found 100% matching be- 
tween the nucleotide sequences of the lymphoma 
cDNA leader and the ‘intron-exon’ junction that 
we have mapped on the genomic DNA while a high 
degree of divergence exists at this level between 
these sequences and that of thymic cDNA. Such a 
variation in the 5 ‘-proximal structure of two c- 
myb cDNAs most probably reflects tissue-specific 
initiation of transcription, rather than solely alter- 
native splicing process. This would account for the 
different structure of leader sequences in thymic 
and yolk sac c-myb RNA (fig.5). The lack of 
hybridization between yolk sac c-myb RNA and 
P804 DNA also raised another interesting ques- 
tion, since we have mapped in this fragment 119 
nucleotides represented in lymphoma cDNA 
(fig.4). Furthermore, preliminary results obtained 
in mapping the 5 ‘-terminus of yolk sac c-myb 
mRNA (not shown) were consistent with the 
presence of a promoter region at the 5 ‘-end of 
P504 DNA. Interestingly, an ATG codon, located 
at position 38 in the Pst049 c-myb exon (fig.3) ap- 
pears to be in phase with the remainder of the c- 
myb protein, and sequencing of DNA upstream of 
this exon allowed us to recognize both a potential 
TATA box (TAATTAA) and a -80 region 
(GAACAAAA) at positions 59 and 135, respec- 
tively, from the 3 ‘-end of EP180 DNA. 
To explain all these observations, we propose 
that different promoter regions are used to initiate 
c-myb transcription in hematopoietic cells of dif- 
ferent origins. Our preliminary results indicate that 
the genomic sequences homologous to the thymic 
cDNA leader are located several kilobases 
upstream to the exon containing the ATG initia- 
tion codon found in lymphoma cDNA. This model 
would also account for the expression of more 
than one c-myb RNA in hematopoietic ells ([25]; 
unpublished) and would be in agreement with 
previous reports suggesting that transcription of 
the murine c-myb locus might be initiated at multi- 
ple sites [6,26]. Alternative splicing has already 
been associated with tissue-specific expression of 
mRNA [27] and a shift in promoter utilisation is 
well documented in the case of the c-myc gene 
[28-3 11. More recently, it has been shown that 
transcription of the NMYC locus also initiates at 
numerous sites that may be under the control of 
two promoters and involves alternative splicing 
[32]. Experiments are now in progress to establish 
the precise organization of the regulatory se- 
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quences governing the tissue-specific expression of 
c-m@ and to determine whether the expression of 
different c-myb mRNAs can be correlated with 
particular stages of hematopoiesis and tumor 
genesis. 
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